This service funds the guideline directed management of eligible patients with abnormal uterine bleeding who would benefit from further investigation and/or treatment

Cervical cancer is one of the most preventable cancers. Early detection of persistent HPV infections through HPV Primary Screening, in addition to HPV vaccination efforts, is intended to help the country meet its goal of eliminating cervical cancer.

This programme provides funding for contraceptive consultation including administration of Depo Provera, and the insertion of contraceptive implants and IUDs to target populations. Vasectomies for priority men are funded under this programme.

This service funds both education and practice costs for the insertion of ring pessaries

Treatment for women who are haemodynamically stable with pelvic pain and can be safely managed in the community. Investigation of retained products of conception where the patient no longer qualifies for maternity funding.

This service funds the guideline directed management of eligible patients with abnormal uterine bleeding who would benefit from further investigation and/or treatment

Cervical cancer is one of the most preventable cancers. Early detection of persistent HPV infections through HPV Primary Screening, in addition to HPV vaccination efforts, is intended to help the country meet its goal of eliminating cervical cancer.

This programme provides funding for contraceptive consultation including administration of Depo Provera, and the insertion of contraceptive implants and IUDs to target populations.

This service provides funding for up to two GP/NP consults per māma for up to eight weeks post-delivery.

This service funds both education and practice costs for the insertion of ring pessaries

Treatment for women who are haemodynamically stable with pelvic pain and can be safely managed in the community. Investigation of retained products of conception where the patient no longer qualifies for maternity funding.

This service funds the guideline directed management of eligible patients with abnormal uterine bleeding who would benefit from further investigation and/or treatment